On May 1, 2009, there was a recall of 14 Hydroxycut diet-aid products springing from a number of reports that people using the products were developing significant liver problems and other health issues. Less than 7 days later, on May four, the first Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company laxity in informing the public about potential risks of the products. Naturally, it’s too shortly to grasp the suit is going to turn out, but if the company had information which it did not reveal to consumers, it should definitely be held accountable.

A class action legal action is filed by a group of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and far less pricey, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost anything unless there’s a settlement. At that point, the lawyer who handled the suit will take his charges from the compensation that was given and then distribute the leftover funds to the litigants in the case. Since this is the case, you’ll be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action suits became so popular.

The 1st class action legal action against Iovate was filed in Canada where the company is found and represents all Canadian voters who sustained health problems due to Hydroxycut products. The FDA recall happened in the U. S. Where twenty-three cases of liver disorders and other health problems had been reported. Health Canada failed to receive any reports of liver damage caused by the diet products, but they did receive seventeen reports concerning folks who sustained respiratory, neurological, heart, and gut issues as a consequence of Canadians using the products.

The Hydroxycut Settlement Suit alleges that the products without correctly informing the general public of the health hazards that they could exposing consumers to. The complaint states that the company did not publish the data on the product labels saying that users could run the risk of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological problems. The suit goes on to allege that this was an obvious omission on the part of the company which deliberately misled buyers concerning the security of the products.